BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 4398509)

  • 1. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
    Monaco AP; Gozzo JJ; Wood ML; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML; Gozzo JJ; Monaco AP
    Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
    [No Abstract]   [Full Text] [Related]  

  • 4. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone-marrow transplantation in France, 1958-1973.
    Mathé G; Schwarzenberg L
    Transplant Proc; 1974 Dec; 6(4):335-43. PubMed ID: 4155150
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
    Pegrum GD; Williams G; Markwick J; Barnes RM
    Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antilymphoid globulin in the therapy of secondary disease.
    Corneci I; Andrian T; Costachel O; Feteanu A
    Transplant Proc; 1971 Mar; 3(1):422-6. PubMed ID: 4398500
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum.
    Gozzo JJ; Wood ML; Monaco AP
    Surg Forum; 1970; 21():281-4. PubMed ID: 4936984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histological studies on graft versus host reaction in the mouse after treating the donor animal with antilymphocyte serum].
    Beil E; Becker G; Thierfelder S; Mempel W; Rodriguez E
    Verh Dtsch Ges Pathol; 1970; 54():191-7. PubMed ID: 4104529
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.
    Lotzová E
    Exp Hematol; 1977 May; 5(3):215-35. PubMed ID: 326573
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic marrow transplantation using matched sibling donors.
    Thomas ED
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):115-9. PubMed ID: 4155158
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppression for clinical marrow transplantation.
    Santos GW
    Semin Hematol; 1974 Jul; 11(3):341-51. PubMed ID: 4151847
    [No Abstract]   [Full Text] [Related]  

  • 18. Graft-versus-host reactions in bone marrow transplantation.
    Meuwissen HJ; Kersey J; Pabst H; Gatti R; Chilgren R; Good RA
    Transplant Proc; 1971 Mar; 3(1):414-7. PubMed ID: 4398498
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.
    Trier L; Rubin B
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):724-32. PubMed ID: 4139875
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation].
    Jeannet M; Vaucher A; Gervasoni C
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1598-600. PubMed ID: 4405059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.